UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

Jan. 16, 2025 — A new report shows the benefit of wearing contact lenses for slowing myopia has a lasting effect -- good news since 50% of the world (5 billion people) will likely be nearsighted ...

Many theories have been brought forward to account for the disease. Of these the myopathic theory has been most supported in England, chiefly owing to the writings of the late Mr. Simeon Snell ...

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...